Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Aptorum Group Limited (APM)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
a month ago | Benzinga
a month ago | Business Wire
a month ago | Business Wire
2 months ago | Business Wire
2 months ago | Benzinga
2 months ago | Business Wire
3 months ago | Business Wire
3 months ago | Business Wire
Aptorum Shares Are Trading Higher On Immunomodulators Agreement For Autoimmune, Oncology Indications
3 months ago | Benzinga
3 months ago | Pulse2